Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Serrano

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
Neuroscience Letters|May 2, 2022
Attenuation of oleoylethanolamide-induced reduction of alcohol consumption in adult rats exposed intermittently to alcohol during adolescenceLaura Sánchez-Marín, Francisco J Pavón-Morón, Fernando Rodríguez de Fonseca, et al.
Plos One|November 16, 2013
Description of the protocols for randomized controlled trials on cancer drugs conducted in Spain (1999-2003)Xavier Bonfill, Mónica Ballesteros, Ignasi Gich, et al.
Sensors (Basel, Switzerland)|July 24, 2021
Spectral Relative Attenuation of Solar Radiation through a Skylight Focused on Preventive Conservation: Museo De L'almoina in Valencia (Spain) Case StudyMaría-Antonia Serrano, José-Luis Baró Zarzo, Juan-Carlos Moreno Esteve, et al.
Neuropharmacology|December 22, 2010
Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intakeAntonia Serrano, Francisco Javier Pavón, Sulay Tovar, et al.
Advances in Experimental Medicine and Biology|August 1, 2023
Clinical Trials on Advanced Therapy Investigational Medicinal Products in Spain (2004-2022): Experience and Challenges for the FutureJuan Estévez Álamo, Marcos Timón, Isabel Sánchez Afán de Rivera, et al.
Neuropharmacology|May 1, 2007
The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker ratsAntonia Serrano, Ignacio Del Arco, Francisco Javier Pavón, et al.
Journal of Medicinal Chemistry|January 19, 2007
Novel sulfamide analogs of oleoylethanolamide showing in vivo satiety inducing actions and PPARalpha activationCarolina Cano, Javier Pavón, Antonia Serrano, et al.
Alcoholism, Clinical and Experimental Research|December 7, 2011
Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdalaAntonia Serrano, Patricia Rivera, Francisco J Pavon, et al.
Frontiers in Neuroanatomy|March 28, 2014
Localization of peroxisome proliferator-activated receptor alpha (PPARα) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampusPatricia Rivera, Sergio Arrabal, Antonio Vargas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Galanin N-terminal fragment (1-15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic systemNoelia Cantero-García, Antonio Flores-Burgess, Juan Pedro Pineda-Gómez, et al.
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
Neuroscience Letters|May 2, 2022
Attenuation of oleoylethanolamide-induced reduction of alcohol consumption in adult rats exposed intermittently to alcohol during adolescenceLaura Sánchez-Marín, Francisco J Pavón-Morón, Fernando Rodríguez de Fonseca, et al.
Plos One|November 16, 2013
Description of the protocols for randomized controlled trials on cancer drugs conducted in Spain (1999-2003)Xavier Bonfill, Mónica Ballesteros, Ignasi Gich, et al.
Sensors (Basel, Switzerland)|July 24, 2021
Spectral Relative Attenuation of Solar Radiation through a Skylight Focused on Preventive Conservation: Museo De L'almoina in Valencia (Spain) Case StudyMaría-Antonia Serrano, José-Luis Baró Zarzo, Juan-Carlos Moreno Esteve, et al.
Neuropharmacology|December 22, 2010
Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intakeAntonia Serrano, Francisco Javier Pavón, Sulay Tovar, et al.
Advances in Experimental Medicine and Biology|August 1, 2023
Clinical Trials on Advanced Therapy Investigational Medicinal Products in Spain (2004-2022): Experience and Challenges for the FutureJuan Estévez Álamo, Marcos Timón, Isabel Sánchez Afán de Rivera, et al.
Neuropharmacology|May 1, 2007
The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker ratsAntonia Serrano, Ignacio Del Arco, Francisco Javier Pavón, et al.
Journal of Medicinal Chemistry|January 19, 2007
Novel sulfamide analogs of oleoylethanolamide showing in vivo satiety inducing actions and PPARalpha activationCarolina Cano, Javier Pavón, Antonia Serrano, et al.
Alcoholism, Clinical and Experimental Research|December 7, 2011
Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdalaAntonia Serrano, Patricia Rivera, Francisco J Pavon, et al.
Frontiers in Neuroanatomy|March 28, 2014
Localization of peroxisome proliferator-activated receptor alpha (PPARα) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampusPatricia Rivera, Sergio Arrabal, Antonio Vargas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Galanin N-terminal fragment (1-15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic systemNoelia Cantero-García, Antonio Flores-Burgess, Juan Pedro Pineda-Gómez, et al.
Pageof 18